Phase 2 Hyperuricemia Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd.340 enrolled1 locationNCT07362355
Recruiting
Phase 2
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics25 enrolled8 locationsNCT07116746
Recruiting
Phase 1Phase 2
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd.60 enrolled6 locationsNCT06310967